Suchergebnisse - "Martinez-Jañez, Noelia"

PubPharm (36)

1

Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer : The randomized Tempo Breast study

enthalten in: Breast (Edinburgh, Scotland) | 2024

von Freyer, G. | Martinez-Jañez, N. | Kukielka-Budny, B. | +17

2

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors

enthalten in: Cancers | 2023

von Saavedra, C. | Vallejo, A. | Longo, F. | +13

3

Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases

enthalten in: Cancers | 2023

von Carretero-Barrio, I. | Caniego-Casas, T. | Rosas, M. | +7

4

Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer : patient-reported outcomes from the FLIPPER trial

enthalten in: Therapeutic advances in medical oncology | 2023

von Tibau, A. | Martínez, M. | Ramos, M. | +17

5

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer : case report and review of literature

enthalten in: Frontiers in oncology | 2023

von Albarrán, V. | Chamorro, J. | Pozas, J. | +10

6

The impact of cyclin-dependent kinases 4 and 6 inhibitors in the immune response to mRNA SARS-CoV-2 vaccine in women with breast cancer.

enthalten in: ResearchSquare.com | 2022

von Saavedra, C. | Vallejo, A. | Longo, F. | +13

7

The impact of cyclin-dependent kinases 4 and 6 inhibitors in the immune response to mRNA SARS-CoV-2 vaccine in women with breast cancer.

enthalten in: ResearchSquare.com | 2022

von Saavedra, C. | Vallejo, A. | Longo, F. | +13

8

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer : Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Salvador Bofill, J. | Moreno Anton, F. | Rodriguez Sanchez, C. | +24

9

Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Cortés, A. | Casado, J. | Longo, F. | +24

10

Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von García-Sáenz, J. | Martínez-Jáñez, N. | Cubedo, R. | +14